Author:
Haj Mohammad N.,ter Veer E.,Ngai L.,Mali R.,van Oijen M. G. H.,van Laarhoven H. W. M.
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Al-Batran, S. E., & Ajani, J. A. (2010). Impact of chemotherapy on quality of life in patients with metastatic esophagogastric cancer. Cancer, 116(11), 2511–8.
2. Murad, A. M., et al. (1993). Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer, 72(1), 37–41.
3. Pyrhonen, S., et al. (1995). Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. British Journal of Cancer, 71(3), 587–91.
4. Koizumi, W., et al. (2008). S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncology, 9(3), 215–21.
5. Levi, J. A., et al. (1986). Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies. Journal of Clinical Oncology, 4(9), 1348–55.
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献